Protein kinase C activation can reduce tumor growth of CRC cells (Glimelius et al. 2010), and protein kinase C beta II could inhibit CRC by modulating IGF-1-mediated cell survival (Dowling et al. 2016). Here, IGF1 is linked to colorectal carcinoma.